Promius Pharma LLC-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Promius Pharma LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013259
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Promius Pharma LLC (Promius Pharma) a subsidiary of Dr. Reddy’s Laboratories Ltd is a provider of dermatology and neurology products. The company’s products include clocortolone pivalate, promiseb topical cream, coal tar, betamethasone dipropionate, triamcinolone acetonide ointment, USP, sumatriptan injection and isotretinoin capsules USP. Its promiseb topical cream is used for the treatment of seborrheic dermatitis. Promius Pharma has operational research and development laboratories for product ideation, product formulation, and analytics and testing. The company conducts research and development to develop new products. Promius Pharma is headquartered in Princeton, New Jersey, the US.

Promius Pharma LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Promius Pharma LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Promius Pharma LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Promius Pharma LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Promius Pharma LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Promius Pharma LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Promius Pharma LLC, Pharmaceuticals & Healthcare, Deal Details 10
Licensing Agreements 10
Encore Dermatology Enters into Licensing Agreement with Promius Pharma 10
Promius Pharma Enters into Licensing Agreement with CMP Pharma for Trianex 11
Promius Pharma Enters Into Licensing With Valeant Pharma For Cloderm Cream 12
Promius Pharma LLC – Key Competitors 13
Promius Pharma LLC – Key Employees 14
Promius Pharma LLC – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Promius Pharma LLC, Pharmaceuticals & Healthcare, Key Facts 2
Promius Pharma LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Promius Pharma LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Promius Pharma LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Promius Pharma LLC, Deals By Therapy Area, 2011 to YTD 2017 8
Promius Pharma LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Encore Dermatology Enters into Licensing Agreement with Promius Pharma 10
Promius Pharma Enters into Licensing Agreement with CMP Pharma for Trianex 11
Promius Pharma Enters Into Licensing With Valeant Pharma For Cloderm Cream 12
Promius Pharma LLC, Key Competitors 13
Promius Pharma LLC, Key Employees 14

★海外企業調査レポート[Promius Pharma LLC-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AB Orlen Lietuva:企業の戦略的SWOT分析
    AB Orlen Lietuva - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Brookfield Property REIT Inc (GGP):企業の財務・戦略的SWOT分析
    Brookfield Property REIT Inc (GGP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Iberdrola SA (IBE):電力:M&Aディール及び事業提携情報
    Summary Iberdrola SA (Iberdrola) is an energy utility. It constructs, operates, and manages power generation plants, transmission and distribution facilities, and other assets. The company produces electricity using conventional and renewable energy sources. Iberdrola also trades electricity and gas …
  • Phenex Pharmaceuticals AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Phenex Pharmaceuticals AG (Phenex Pharmaceuticals) is a drug discovery and development company that offers nuclear receptors for the development of novel therapies. The company offer services such as NR selectivity screening, contract screening services, and SNuRM profiling to pharmaceutical …
  • European Investment Bank:企業の戦略的SWOT分析
    European Investment Bank - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Accu-Break Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Accu-Break Pharmaceuticals Inc (Accu-Break) is a developer and provider of pharmaceutical tablet technologies for accurate and customized dosing. The company provides services such as patented technologies, product differentiation, life cycle management, APIs solutions, product enhancement, …
  • Tervita Corp:企業の戦略・SWOT・財務情報
    Tervita Corp - Strategy, SWOT and Corporate Finance Report Summary Tervita Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • GSE Group:企業の戦略・SWOT・財務情報
    GSE Group - Strategy, SWOT and Corporate Finance Report Summary GSE Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Wegmans Food Markets, Inc.:企業の戦略・SWOT・財務分析
    Wegmans Food Markets, Inc. - Strategy, SWOT and Corporate Finance Report Summary Wegmans Food Markets, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • MKS Instruments Inc (MKSI):企業の財務・戦略的SWOT分析
    MKS Instruments Inc (MKSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Schlumberger Ltd (SLB):企業の財務・戦略的SWOT分析
    Schlumberger Ltd (SLB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Crown Van Gelder N.V.:企業の戦略・SWOT・財務分析
    Crown Van Gelder N.V. - Strategy, SWOT and Corporate Finance Report Summary Crown Van Gelder N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Veikkaus Oy:企業の戦略的SWOT分析
    Veikkaus Oy - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Interface Biologics Inc:製品パイプライン分析
    Summary Interface Biologics Inc (IBI) is a developer transformative biomedical polymer technology. The company offers anti-thrombogenic and combination drug delivery devices. Its blood contacting medical devices uses Endexo technology address problems related to thrombosis. IBI’s technologies includ …
  • American Airlines Group Inc.:企業の戦略・SWOT・財務情報
    American Airlines Group Inc. - Strategy, SWOT and Corporate Finance Report Summary American Airlines Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Plenus Company Limited:企業の戦略・SWOT・財務情報
    Plenus Company Limited - Strategy, SWOT and Corporate Finance Report Summary Plenus Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Bharat Heavy Electricals Ltd:企業の戦略・SWOT・財務分析
    Bharat Heavy Electricals Ltd - Strategy, SWOT and Corporate Finance Report Summary Bharat Heavy Electricals Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Basler Kantonalbank AG:企業の戦略・SWOT・財務情報
    Basler Kantonalbank AG - Strategy, SWOT and Corporate Finance Report Summary Basler Kantonalbank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Symrise AG (SY1):企業の財務・戦略的SWOT分析
    Symrise AG (SY1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Puncak Niaga Holdings Bhd (PUNCAK):企業の財務・戦略的SWOT分析
    Puncak Niaga Holdings Bhd (PUNCAK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆